CAS 41307-63-5

3',6'-dihydroxy-3H-spiro[benzo[de]isochromene-1,9'-xanthen]-3-one

Description:

3',6'-Dihydroxy-3H-spiro[benzo[de]isochromene-1,9'-xanthen]-3-one, with the CAS number 41307-63-5, is a chemical compound characterized by its complex spirocyclic structure, which incorporates both a benzo[de]isochromene and a xanthenone moiety. This compound features two hydroxyl groups at the 3' and 6' positions, contributing to its potential reactivity and solubility properties. The presence of these hydroxyl groups can enhance its ability to form hydrogen bonds, influencing its interactions in biological systems and its potential applications in pharmaceuticals or as a dye. The spiro structure provides unique geometric and electronic properties, which may affect its optical characteristics, making it of interest in materials science and organic electronics. Additionally, the compound may exhibit fluorescence, which is a valuable property for applications in imaging and sensing technologies. Overall, the unique structural features of this compound suggest a range of potential applications in various fields, including medicinal chemistry and materials science.

Formula: C₂₄H₁₄O₅

InChI: InChI=1/C24H14O5/c25-14-7-9-17-20(11-14)28-21-12-15(26)8-10-18(21)24(17)19-6-2-4-13-3-1-5-16(22(13)19)23(27)29-24/h1-12,25-26H

SMILES: c1cc2cccc3c2c(c1)C(=O)OC13c2ccc(cc2Oc2cc(ccc12)O)O

Resorcinolnaphthalein

CAS: 41307-63-5

Resorcinolnaphthalein is a specific enhancer of angiotensin-converting enzyme 2 (ACE2) (EC50 value of 19.5 μM).

Formula: C₂₄H₁₄O₅

Purity: 98.18%

Color and Shape: Solid

Molecular weight: 382.36

Ref: TM-T13865

Resorcinolnaphthalein

CAS: 41307-63-5

Resorcinolnaphthalein

Purity: ≥98%

Molecular weight: 382.36g/mol

Ref: 54-BUP11457

Resorcinolnaphthalein

CAS: 41307-63-5

Resorcinolnaphthalein is a non-steroidal anti-inflammatory drug that is used to treat chronic pulmonary diseases and other inflammatory conditions. Resorcinolnaphthalein has been shown to inhibit the production of proinflammatory cytokines such as IL-10, and also has the ability to modulate autophagy. It has been shown in vitro to activate the transcription of pro-inflammatory cytokines, chemokines, and adhesion molecules in response to lipopolysaccharides (LPS). Resorcinolnaphthalein also inhibits angiotensin II, which may be responsible for its antihypertensive effects. Transgenic animal studies have shown that resorcinolnaphthalein inhibits airway hyperresponsiveness and pulmonary hypertension induced by chronic cigarette smoke exposure.

Formula: C₂₄H₁₄O₅

Purity: Min. 95%

Molecular weight: 382.4 g/mol

Ref: 3D-RBA30763